LEXICON PHARMACEUTICALS, INC. — Director's Dealing 2020

Apr 27, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LEXICON PHARMACEUTICALS, INC. (LXRX)
CIK: 0001062822
Period of Report: 2020-04-24

Reporting Person: Palantoni Frank (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-04-26	Common Stock	M	3466	—	Acquired	16368	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-04-24	Stock Option (Right to Buy)	$1.86	A	18115	Acquired	2030-04-24	Common Stock (18115)	Direct
2020-04-24	Restricted Stock Units	$0	A	10638	Acquired		Common Stock (10638)	Direct
2020-04-26	Restricted Stock Units	$	M	3466	Disposed		Common Stock (3466)	Direct

Footnotes

F1: Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date.

F2: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date.

F3: Each restricted stock unit represents a contingent right to receive one share of common stock.